SCHEMBL5323960

SCHEMBL5323960

O=C1C=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15226499 0.80
SCHEMBL296266 0.80
SCHEMBL10465266 0.76
SCHEMBL7178562 0.75 GSK3A (0.50)
SCHEMBL16837114 0.73
SCHEMBL13113506 0.73
SCHEMBL329018 0.73 ALDH1A1 (0.48)
SCHEMBL18151643 0.73
SCHEMBL7887724 0.73 GSK3A (0.33)
SCHEMBL329019 0.73 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113126431-B Photosensitive bismaleimide composition 罗门哈斯电子材料有限责任公司 2024-10-01 CN claimed
CN-114426510-B Synthesis method of fully substituted beta-lactam 常州大学 2024-01-23 CN claimed
CN-110818672-B Cyclobutenone compound with antioxidant effect and preparation method thereof 江门市翰尔威新材料有限公司 2022-06-24 CN claimed
CN-114426510-A Synthesis method of fully-substituted beta-lactam 常州大学 2022-05-03 CN claimed
EP-3250642-A1 SQUARAINE-BASED MOLECULES AS MATERIAL FOR ORGANIC PHOTOELECTRIC CONVERSION LAYERS IN ORGANIC PHOTODIODES Sony Corporation (JP) 2017-12-06 EP claimed
WO-2016120166-A1 SQUARAINE-BASED MOLECULES AS MATERIAL FOR ORGANIC PHOTOELECTRIC CONVERSION LAYERS IN ORGANIC PHOTODIODES SONY CORPORATION (JP) 2016-08-04 WO claimed
JP-2002517423-A 2002-06-18 JP claimed
US-6395724-B1 COMPLEXES; ANTIINFLAMMATORY AGENTS; ANALGESICS; ANTIPYRETICS ADVANCED MEDICINE, INC. 2002-05-28 US claimed
WO-1999063939-A9 MULTIBINDING INHIBITORS OF CYCLOOXYGENASE-2 ADVANCED MEDICINE INC (US) 2001-04-12 WO claimed
EP-1085845-A2 MULTIBINDING INHIBITORS OF CYCLOOXYGENASE-2 Advanced Medicine, Inc. (US) 2001-03-28 EP claimed
WO-1999063939-A2 MULTIBINDING INHIBITORS OF CYCLOOXYGENASE-2 ADVANCED MEDICINE, INC. (US) 1999-12-16 WO claimed
US-12502376-B2 Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-23 US disclosed
CN-121064111-A Method for synthesizing 1, 4-diazaseven-membered heterocyclic compound 常州大学 2025-12-05 CN disclosed
US-20250339458-A1 USES OF MODIFIED RNA ENCODING RETINALDEHYDE DEHYDROGENASE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2025-11-06 US disclosed
EP-4619376-A2 CYCLIC DESIGNER SCAFFOLDS FOR THE COVALENT TARGETING OF PROTEINS VIA MICHAEL ADDITION Protenic Fejleszto Es Szolgaltato Kft. (HU) 2025-09-24 EP disclosed
US-5703081-A CELL ADHESION INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-12-30 US disclosed
US-5595723-A LIQUID WITH HIGH VAPOR PRESSURE DISPERSED IN LIQUID, ULTRASOUND CONTRAST AGENTS SONUS PHARMACEUTICALS (US) 1997-01-21 US disclosed
EP-0614664-A1 Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-09-14 EP disclosed
US-5075488-A Fungicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-12-24 US disclosed
US-4273916-A Curable cycloaliphatic epoxy-polyimide compositions TRW INC. (US) 1981-06-16 US disclosed